- EMEA Innovative Medicine
- Grant disclosures
J&J Innovative Medicine South Africa
Johnson & Johnson South Africa was the third Operating Company established outside the United States in 1930, maintaining a commitment to providing innovative solutions to patients in South Africa for almost a century. At Johnson & Johnson Innovative Medicine South Africa, we aspire to improve individual patient health outcomes, enable health system productivity, improve population health and maintain sustainable innovation for patients today and tomorrow.
Transparency
The following provides detailed reports on our Transfers of Value (ToV) with patient advocacy groups, reflecting our dedication to compliance and fostering trust within the medical community.
Oncology
Campaigning for Cancer
Campaigning for Cancer is a patient advocacy organisation formed in 2008 to give a voice to South African cancer patients and those affected by cancer. The pioneer of South African cancer patient advocacy, Campaigning for Cancer continues to advocate for the promotion and protection of the rights of patients and those affected by cancer with regard to policy, healthcare costs and healthcare delivery. Campaigning for Cancer does this on an individual patient level – changing one life at a time – by providing people with the knowledge and tools to see their treatment process through; as well as on a larger scale, by noting issues highlighted by these individual cases and advocating for policy change that will affect all of society.
City of Organisation: Johannesburg, South Africa
Web address of organisation: campaign4cancer.co.za
Project description: Multiple Myeloma Patient Advisory Board to gain patient insights into their understanding of multiple myeloma.
Contract signed: 23 March 2021
Fee for service: R20 500.00
Project description: Support for the creation of blood cancer information on the C4C portal pages.
The objective of this program is to aid South African cancer patients in accessing credible and reliable information about their disease and their cancer journey. The platform will inform and aid patients and those affect by blood cancer in managing their rights and responsibilities by providing tools & point of referral across the cancer landscape to aid them at the point of symptoms, diagnosis and during treatment, palliation and survivorship.
Contract signed: 19 November 2020
Contribution made by Janssen: R100 000.00
Project description: Patient Advocacy Group Capability Building Project
Contract signed: 19 November 2020
Contribution made by Janssen: R340 000.00
Project description: CLL Awareness Campaign to facilitate the furthering of CLL awareness in South Africa
Contract signed: 19 November 2020
Contribution made by Janssen: R133 000.00
Project description: Multiple Myeloma Awareness Campaign to facilitate the furthering of Multiple Myeloma awareness in South Africa
Contract signed: 17 March 2020
Contribution made by Janssen: R149 000.00
Campaigning for Cancer is a patient advocacy organisation formed in 2008 to give a voice to South African cancer patients and those affected by cancer. The pioneer of South African cancer patient advocacy, Campaigning for Cancer continues to advocate for the promotion and protection of the rights of patients and those affected by cancer with regard to policy, healthcare costs and healthcare delivery. Campaigning for Cancer does this on an individual patient level – changing one life at a time – by providing people with the knowledge and tools to see their treatment process through; as well as on a larger scale, by noting issues highlighted by these individual cases and advocating for policy change that will affect all of society.
City of Organisation: Johannesburg, South Africa
Web address of organisation: campaign4cancer.co.za
Project description: Multiple Myeloma Patient Advisory Board to gain patient insights into their understanding of multiple myeloma.
Contract signed: 23 March 2021
Fee for service: R20 500.00
Project description: Support for the creation of blood cancer information on the C4C portal pages.
The objective of this program is to aid South African cancer patients in accessing credible and reliable information about their disease and their cancer journey. The platform will inform and aid patients and those affect by blood cancer in managing their rights and responsibilities by providing tools & point of referral across the cancer landscape to aid them at the point of symptoms, diagnosis and during treatment, palliation and survivorship.
Contract signed: 19 November 2020
Contribution made by Janssen: R100 000.00
Project description: Patient Advocacy Group Capability Building Project
Contract signed: 19 November 2020
Contribution made by Janssen: R340 000.00
Project description: CLL Awareness Campaign to facilitate the furthering of CLL awareness in South Africa
Contract signed: 19 November 2020
Contribution made by Janssen: R133 000.00
Project description: Multiple Myeloma Awareness Campaign to facilitate the furthering of Multiple Myeloma awareness in South Africa
Contract signed: 17 March 2020
Contribution made by Janssen: R149 000.00
Immunology
IBD Africa
Inflammatory Bowel Disease Africa or IBD Africa is a South African non-profit company, launched in 2019 with the aim of improving inflammatory bowel disease (IBD) care in sub–Saharan Africa through IBD RESEARCH, EDUCATION and ADVOCACY.
IBD Africa Patient Advocacy Summit. The future healthcare environment for IBD patients presents many challenges in the form of escalating private healthcare costs, NHI and limited access to the rapidly expanding treatment options for IBD. IBD patient advocacy is in its infancy in South Africa but this is changing rapidly with IBD Africa’s programs to develop effective IBD patient advocates. The programs include their first Advocacy Summit in 2022, patient participation at the main SAGES Congress in 2023 and education around advocacy issues on social media platforms. The 2023 summit will again focus on patient advocacy and also the development of an Patient Advocacy Manual.
Project description: IBD Africa Patient Advocacy Summit 2023
Contract signed: 26 October 2023
City of organisation: Pinelands, South Africa
Web address of organisation: ibdafrica.org
Contribution made by Janssen: R45 000.00
Axial Spondyloarthritis Association of South Africa (ASASA)
AxSpaSA was established in 2018 and became a registered NPO in December 2020. It is a patient driven organization with the vision to be the primary resource for people diagnosed and living with Axial Spondyloarthritis (AxSpA) & related diseases in South Africa. They aim to empower everyone with axial spondyloarthritis (axSpA) including ankylosing spondylitis (AS) to manage their treatment and to stay in control of their lives. They are driven to ensure that health care professionals in South Africa deliver tailored and timely care to every patient, every time.
Project description: Patient Research Program
Contract signed: 14 September 2023
City of Organisation: Mosselbaai, Western Cape, South Africa
Web address of organisation: axspasa.org.za/
Contribution made by Janssen: R45 000.00
Axial Spondyloarthritis Association of South Africa (AxSpaSA)
AxSpaSA was established in 2018 and became a registered NPO in December 2020. It is a patient driven organization with the vision to be the primary resource for people diagnosed and living with Axial Spondyloarthritis (AxSpA) & related diseases in South Africa.
Project description: Content development for patients
Contract signed: 22 September 2021
City of Organisation: Mosselbaai, Western Cape, South Africa
Contribution made by Janssen: R30 000.00
Arthritis Foundation
The Arthritis Foundation of South Africa is a non-profit organisation aiming to create awareness around arthritis in South Africa.
“The Arthritis Foundation of South Africa is the only body in our country providing non-medical support for arthritis patients, their families and carers. To do this we are involved in a wide range of education and support programmes, in providing access to information about these diseases, and by advocating the interests of people with arthritis in government, medical and media circles.”
Project description: Arthritis Insight Magazine Summer edition 2019
Contract signed: 23 July 2019
City of organisation: Cape Town, South Arica
Web address of organisation: arthritis.org.za
Contribution made by Janssen: R45 000.00
IBD Africa
IBD Africa is a non-profit organisation aiming to create awareness around IBD in Southern Africa.
“As part of our ongoing commitment to IBD care, education and advocacy in South Africa, IBD Arica would like to produce videos of patients sharing their journey with IBD. The main aim of this project is to create awareness around IBD to educate and encourage patients to better understand and manage their disease.”
Project description: IBD Africa Patient Video Project
Contract signed: 31 July 2019
City of organisation: Pinelands, South Africa
Web address of organisation: ibdafrica.org
Contribution made by Janssen: R20 000.00
Bloem Arthritis NPC
Bloem Arthritis NPC is a non-profit organization aiming to create awareness around arthritis, auto-immune diseases and the medication that is involved in treating these conditions.
“By creating awareness amongst the population living with arthritis, we want to enable people to help themselves by knowing what is available in terms of medication and have greater support from their families and friends and the medical persons involved. The end goal is to have an impact on their quality of life, their future and to establish a well-supported network amongst these living with arthritis.”
Project description: Patient education and support program
Contract signed: 10 May 2017
City of organization: Bloemfontein, South Africa
Web address of organization: N/A
Contribution made by Janssen: R14 622.50
Inflammatory Bowel Disease Africa or IBD Africa is a South African non-profit company, launched in 2019 with the aim of improving inflammatory bowel disease (IBD) care in sub–Saharan Africa through IBD RESEARCH, EDUCATION and ADVOCACY.
IBD Africa Patient Advocacy Summit. The future healthcare environment for IBD patients presents many challenges in the form of escalating private healthcare costs, NHI and limited access to the rapidly expanding treatment options for IBD. IBD patient advocacy is in its infancy in South Africa but this is changing rapidly with IBD Africa’s programs to develop effective IBD patient advocates. The programs include their first Advocacy Summit in 2022, patient participation at the main SAGES Congress in 2023 and education around advocacy issues on social media platforms. The 2023 summit will again focus on patient advocacy and also the development of an Patient Advocacy Manual.
Project description: IBD Africa Patient Advocacy Summit 2023
Contract signed: 26 October 2023
City of organisation: Pinelands, South Africa
Web address of organisation: ibdafrica.org
Contribution made by Janssen: R45 000.00
Axial Spondyloarthritis Association of South Africa (ASASA)
AxSpaSA was established in 2018 and became a registered NPO in December 2020. It is a patient driven organization with the vision to be the primary resource for people diagnosed and living with Axial Spondyloarthritis (AxSpA) & related diseases in South Africa. They aim to empower everyone with axial spondyloarthritis (axSpA) including ankylosing spondylitis (AS) to manage their treatment and to stay in control of their lives. They are driven to ensure that health care professionals in South Africa deliver tailored and timely care to every patient, every time.
Project description: Patient Research Program
Contract signed: 14 September 2023
City of Organisation: Mosselbaai, Western Cape, South Africa
Web address of organisation: axspasa.org.za/
Contribution made by Janssen: R45 000.00
Axial Spondyloarthritis Association of South Africa (AxSpaSA)
AxSpaSA was established in 2018 and became a registered NPO in December 2020. It is a patient driven organization with the vision to be the primary resource for people diagnosed and living with Axial Spondyloarthritis (AxSpA) & related diseases in South Africa.
Project description: Content development for patients
Contract signed: 22 September 2021
City of Organisation: Mosselbaai, Western Cape, South Africa
Contribution made by Janssen: R30 000.00
Arthritis Foundation
The Arthritis Foundation of South Africa is a non-profit organisation aiming to create awareness around arthritis in South Africa.
“The Arthritis Foundation of South Africa is the only body in our country providing non-medical support for arthritis patients, their families and carers. To do this we are involved in a wide range of education and support programmes, in providing access to information about these diseases, and by advocating the interests of people with arthritis in government, medical and media circles.”
Project description: Arthritis Insight Magazine Summer edition 2019
Contract signed: 23 July 2019
City of organisation: Cape Town, South Arica
Web address of organisation: arthritis.org.za
Contribution made by Janssen: R45 000.00
IBD Africa
IBD Africa is a non-profit organisation aiming to create awareness around IBD in Southern Africa.
“As part of our ongoing commitment to IBD care, education and advocacy in South Africa, IBD Arica would like to produce videos of patients sharing their journey with IBD. The main aim of this project is to create awareness around IBD to educate and encourage patients to better understand and manage their disease.”
Project description: IBD Africa Patient Video Project
Contract signed: 31 July 2019
City of organisation: Pinelands, South Africa
Web address of organisation: ibdafrica.org
Contribution made by Janssen: R20 000.00
Bloem Arthritis NPC
Bloem Arthritis NPC is a non-profit organization aiming to create awareness around arthritis, auto-immune diseases and the medication that is involved in treating these conditions.
“By creating awareness amongst the population living with arthritis, we want to enable people to help themselves by knowing what is available in terms of medication and have greater support from their families and friends and the medical persons involved. The end goal is to have an impact on their quality of life, their future and to establish a well-supported network amongst these living with arthritis.”
Project description: Patient education and support program
Contract signed: 10 May 2017
City of organization: Bloemfontein, South Africa
Web address of organization: N/A
Contribution made by Janssen: R14 622.50
Neuroscience
Patient education and support program
The South African Federation for Mental Health (SAFMH) is a registered non-profit organization and aims to coordinate, monitor and promote services for persons with intellectual and psychosocial disabilities as well as promoting good mental health and wellbeing amongst the South African public.
The 5th Global Mental Health Summit creates an opportunity to acknowledge and value the voice of Mental Healthcare users and patients with lived experiences.
“By creating this level of awareness, they enable people to help themselves by knowing what is available in terms of medication and have greater support from their families and friends and the medical persons involved. The end goal is to have an impact on their quality of life, their future and to establish a well-supported network.”
Project description: Patient education and support program
Contract signed: 09 January 2018
City of organization: Randburg, South Africa
Web address of organization: www.safmh.org.za
Contribution made by Janssen: R50 000.00
The South African Federation for Mental Health (SAFMH) is a registered non-profit organization and aims to coordinate, monitor and promote services for persons with intellectual and psychosocial disabilities as well as promoting good mental health and wellbeing amongst the South African public.
The 5th Global Mental Health Summit creates an opportunity to acknowledge and value the voice of Mental Healthcare users and patients with lived experiences.
“By creating this level of awareness, they enable people to help themselves by knowing what is available in terms of medication and have greater support from their families and friends and the medical persons involved. The end goal is to have an impact on their quality of life, their future and to establish a well-supported network.”
Project description: Patient education and support program
Contract signed: 09 January 2018
City of organization: Randburg, South Africa
Web address of organization: www.safmh.org.za
Contribution made by Janssen: R50 000.00
Important medicine safety information
At Johnson & Johnson, patient safety is our top priority. Critical safety information, aligned with SAHPRA guidelines, can be found on this page.